BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36418293)

  • 21. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
    Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
    BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease.
    Du Y; Fu M; Huang Z; Tian X; Li J; Pang Y; Song W; Tian Wang Y; Dong Z
    Aging Cell; 2020 Mar; 19(3):e13113. PubMed ID: 32061032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing expression of synapse-restricting protein Ephexin5 ameliorates Alzheimer's-like impairment in mice.
    Sell GL; Schaffer TB; Margolis SS
    J Clin Invest; 2017 May; 127(5):1646-1650. PubMed ID: 28346227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Animal Model to Test Reversal of Cognitive Decline Associated with Beta-Amyloid Pathologies.
    Deba F; Peterson S; Hamouda AK
    Methods Mol Biol; 2019; 2011():393-412. PubMed ID: 31273712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.
    Huber CM; Yee C; May T; Dhanala A; Mitchell CS
    J Alzheimers Dis; 2018; 61(1):265-281. PubMed ID: 29154274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutaredoxin1 Diminishes Amyloid Beta-Mediated Oxidation of F-Actin and Reverses Cognitive Deficits in an Alzheimer's Disease Mouse Model.
    Kommaddi RP; Tomar DS; Karunakaran S; Bapat D; Nanguneri S; Ray A; Schneider BL; Nair D; Ravindranath V
    Antioxid Redox Signal; 2019 Dec; 31(18):1321-1338. PubMed ID: 31617375
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentiviral vector-mediated overexpression of Klotho in the brain improves Alzheimer's disease-like pathology and cognitive deficits in mice.
    Zeng CY; Yang TT; Zhou HJ; Zhao Y; Kuang X; Duan W; Du JR
    Neurobiol Aging; 2019 Jun; 78():18-28. PubMed ID: 30851437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.
    Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX
    Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
    Zhu C; Xu B; Sun X; Zhu Q; Sui Y
    Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β.
    Nies SH; Takahashi H; Herber CS; Huttner A; Chase A; Strittmatter SM
    J Biol Chem; 2021 Oct; 297(4):101159. PubMed ID: 34480901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.
    Dong H; Murphy KM; Meng L; Montalvo-Ortiz J; Zeng Z; Kolber BJ; Zhang S; Muglia LJ; Csernansky JG
    J Alzheimers Dis; 2012; 28(3):579-92. PubMed ID: 22045495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippocampal Proteomic Alteration in Triple Transgenic Mouse Model of Alzheimer's Disease and Implication of PINK 1 Regulation in Donepezil Treatment.
    Zhou X; Xiao W; Su Z; Cheng J; Zheng C; Zhang Z; Wang Y; Wang L; Xu B; Li S; Yang X; Pui Man Hoi M
    J Proteome Res; 2019 Apr; 18(4):1542-1552. PubMed ID: 30484658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gain of PITRM1 peptidase in cortical neurons affords protection of mitochondrial and synaptic function in an advanced age mouse model of Alzheimer's disease.
    Du F; Yu Q; Yan S; Zhang Z; Vangavaragu JR; Chen D; Yan SF; Yan SS
    Aging Cell; 2021 May; 20(5):e13368. PubMed ID: 33951271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of aquaporin1 activates the Wnt signaling pathway to improve cognitive function in a mouse model of Alzheimer's disease.
    Yu B; Zhang J; Li H; Sun X
    Gene; 2020 Sep; 755():144904. PubMed ID: 32540373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.